Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Sarrazin

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Journal of Hepatology|September 28, 2015
The importance of resistance to direct antiviral drugs in HCV infection in clinical practiceChristoph Sarrazin
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 7, 2002
Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significanceChristoph Sarrazin
Journal of Hepatology|March 15, 2021
Treatment failure with DAA therapy: Importance of resistanceChristoph Sarrazin
Deutsche Medizinische Wochenschrift (1946)|August 2, 2024
[Hepatitis C: From diagnosis to global virus elimination]Annika Schmitt, Christoph Sarrazin
Gastroenterology|December 17, 2009
Resistance to direct antiviral agents in patients with hepatitis C virus infectionChristoph Sarrazin, Stefan Zeuzem
Journal of Hepatology|June 13, 2018
Treatment of chronic hepatitis CXavier Forns, Christoph Sarrazin
European Journal of Medical Research|August 5, 2011
New hepatitis C therapies in clinical developmentJohannes Vermehren, Christoph Sarrazin
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
The role of resistance in HCV treatmentJohannes Vermehren, Christoph Sarrazin
Innere Medizin (Heidelberg, Germany)|March 13, 2024
[The status of national and global hepatitis C elimination]Christiana Graf, Christoph Sarrazin
Journal of Hepatology|April 23, 2021
Reply to: "Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings"Julia Dietz, Christoph Sarrazin
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Journal of Hepatology|September 28, 2015
The importance of resistance to direct antiviral drugs in HCV infection in clinical practiceChristoph Sarrazin
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 7, 2002
Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significanceChristoph Sarrazin
Journal of Hepatology|March 15, 2021
Treatment failure with DAA therapy: Importance of resistanceChristoph Sarrazin
Deutsche Medizinische Wochenschrift (1946)|August 2, 2024
[Hepatitis C: From diagnosis to global virus elimination]Annika Schmitt, Christoph Sarrazin
Gastroenterology|December 17, 2009
Resistance to direct antiviral agents in patients with hepatitis C virus infectionChristoph Sarrazin, Stefan Zeuzem
Journal of Hepatology|June 13, 2018
Treatment of chronic hepatitis CXavier Forns, Christoph Sarrazin
European Journal of Medical Research|August 5, 2011
New hepatitis C therapies in clinical developmentJohannes Vermehren, Christoph Sarrazin
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
The role of resistance in HCV treatmentJohannes Vermehren, Christoph Sarrazin
Innere Medizin (Heidelberg, Germany)|March 13, 2024
[The status of national and global hepatitis C elimination]Christiana Graf, Christoph Sarrazin
Journal of Hepatology|April 23, 2021
Reply to: "Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings"Julia Dietz, Christoph Sarrazin
Pageof 30